Tempeh-Based Supplement Decreases Blood Glucose Levels Through Inhibiting Rage and NF-κB Activity in Type 2 Diabetes Mellitus Mice Model DOI Creative Commons

Wayan D Miftakhul Jannah,

Arta Farmawati,

Pramudji Hastuti

et al.

Journal of Health Science and Medical Research, Journal Year: 2024, Volume and Issue: unknown, P. 20241056 - 20241056

Published: April 26, 2024

Objective: Hyperglycemia promotes inflammation through inducing the formation of AGE products, which bind with receptor (RAGE) products in cell membranes, leading to activation necrosis factor–kappa beta (NF-κB). This study aimed analyze effects tempeh-based supplement (TBS) preparations γ-amino butyric acid (GABA) tempeh against mRNA expressions RAGE and NF-κB on pancreas a type 2 diabetes mellitus (DM) mice model. Material Methods: research was quasi-experiment, pre post-tests control design for blood glucose levels; post-test only utilizing expressions. A total 30 male mice, 8-10 weeks old, weighing 20-25 g were divided into 6 treatment groups: non-diabetic, Diabetic, Diabetic+metformin, Diabetic+TBS 10 mg/100 BW, 20 40 BW. STZ induction once day two days preceded by NA create DM model; meanwhile, TBS administrated 21 days.Results: The mean difference fasting levels diabetic+TBS BW group highest when compared diabetic (159.52±1.85) mg/dL. One-way ANOVA revealed statistically significant differences levels, at various dosage group. Relative downregulated Conclusion: can decrease downregulate relative mice.

Language: Английский

Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? DOI
Piero Portincasa, Mohamad Khalil,

Annarita Graziani

et al.

European Journal of Internal Medicine, Journal Year: 2023, Volume and Issue: 119, P. 13 - 30

Published: Oct. 4, 2023

Language: Английский

Citations

29

Pediococcus acidilactici CECT 9879 (pA1c®) and heat inactivated pA1c® (pA1c® HI) ameliorate gestational diabetes mellitus in mice DOI Creative Commons
Deyan Yavorov-Dayliev, Fermı́n I. Milagro, Josune Ayo

et al.

Life Sciences, Journal Year: 2025, Volume and Issue: 362, P. 123359 - 123359

Published: Jan. 4, 2025

Language: Английский

Citations

1

Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice DOI Creative Commons
Xiaotian Mao,

Sabina Birgitte Larsen,

Line Fisker Zachariassen

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: June 3, 2024

Abstract Metabolic syndrome encompasses amongst other conditions like obesity and type-2 diabetes is associated with gut microbiome (GM) dysbiosis. Fecal microbiota transplantation (FMT) has been explored to treat metabolic by restoring the GM; however, concerns on accidentally transferring pathogenic microbes remain. As a safer alternative, fecal virome (FVT, sterile-filtrated feces) advantage over FMT in that mainly bacteriophages are transferred. FVT from lean male donors have shown promise alleviating effects of high-fat diet preclinical mouse study. However, still carries risk eukaryotic viral infections. To address this, recently developed methods applied for removing or inactivating viruses component FVT. Modified FVTs compared unmodified saline diet-induced model C57BL/6 N mice. Contrasted obese control, mice administered modified (nearly depleted viruses) exhibits enhanced blood glucose clearance but not weight loss. The improves liver pathology reduces proportions immune cells adipose tissue non-uniform response. GM analysis suggests bacteriophage-mediated modulation influences outcomes. Optimizing these approaches could lead development safe bacteriophage-based therapies targeting through restoration.

Language: Английский

Citations

6

Akkermansia muciniphila for the Prevention of Type 2 Diabetes and Obesity: A Meta-Analysis of Animal Studies DOI Open Access

Ethan Liu,

Xiangming Ji, Kequan Zhou

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(20), P. 3440 - 3440

Published: Oct. 11, 2024

Background: More than half of the states in U.S. report that over 30% adults are obese. Obesity increases risk many chronic diseases, including type 2 diabetes, hypertension, and cardiovascular disease, can even reduce one’s lifespan. Similarly, prevalence diabetes follows a comparable trend. As result, researchers striving to find solutions obesity rates, with particular focus on gut health, which has been previously linked both diabetes. Recent studies suggest Akkermansia muciniphila (Akk) may have positive probiotic effect preventing onset obesity. Methods: We conducted quantitative meta-analysis 15 qualified animal investigating effects Akk administration as probiotic. Results: The statistical analyses showed significantly reduced body weight gain by 10.4% fasting blood glucose 21.2%, while also improving tolerance 22.1% increasing insulin levels 26.9%. However, our analysis revealed substantial heterogeneity between control experimental groups across all subgroups. Conclusions: Overall, appears be effective at reducing diet-induced Long-term larger sample sizes needed confirm these beneficial effects, current were short duration (less 20 weeks).

Language: Английский

Citations

4

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease DOI Creative Commons
Emidio Scarpellini, Marialaura Scarcella, Jan Tack

et al.

Antioxidants, Journal Year: 2024, Volume and Issue: 13(11), P. 1386 - 1386

Published: Nov. 14, 2024

Background: The gut microbiota constitutes a complex microorganism community that harbors bacteria, viruses, fungi, protozoa, and archaea. human bacterial has been extensively proven to participate in metabolism, immunity, nutrient absorption. Its imbalance, namely “dysbiosis”, linked disordered metabolism. Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the features deranged metabolism leading cause cirrhosis hepatocellular carcinoma. Thus, there pathophysiological link between dysbiosis MASLD. Aims Methods: We aimed review literature data on composition its MASLD describe concept “gut–liver axis”. Moreover, we reviewed approaches for modulation treatment. Results: There consolidated evidence particular associated with stages. model explaining relationship bidirectional organization, physiopathology Oxidative stress keystones pathophysiology fibrosis generation. promising efficacy pre- probiotics reversing patients, therapeutic effects. Few yet encouraging fecal transplantation (FMT) are available literature. Conclusions: characteristic key target reversal treatment via diet, pre/probiotics, FMT remains treatment, prevention, reversal.

Language: Английский

Citations

4

Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes DOI Open Access
Sabrina Donati Zeppa, Marco Gervasi, Alessia Bartolacci

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(22), P. 3951 - 3951

Published: Nov. 19, 2024

Type 2 diabetes (T2D) is a chronic metabolic disorder with heterogeneous etiology encompassing societal and behavioral risk factors in addition to genetic environmental susceptibility. The cardiovascular consequences of account for more than two-thirds mortality among people T2D. Not only does T2D shorten life expectancy, but it also lowers quality associated extremely high health expenditures since diabetic complications raise both direct indirect healthcare costs. An increasing body research indicates connection between gut microbial traits, as numerous alterations the intestinal microorganisms have been noted pre-diabetic individuals. These include pro-inflammatory bacterial patterns, increased permeability, endotoxemia, hyperglycemia-favoring conditions, such alteration glucagon-like peptide-1 (GLP-1) secretion. Restoring homeostasis can be very beneficial preventing co-treating improving antidiabetic therapy outcomes. This review summarizes characteristics "diabetic" microbiota metabolites produced by species that worsen or ameliorate progression, suggesting microbiota-targeted strategies restore eubiosis regulate blood glucose. Nutritional supplementation, diet, physical exercise are known play important roles T2D, here their effects on discussed, non-pharmacological approaches greatly help management highlighting importance tailoring treatments individual needs.

Language: Английский

Citations

4

Verrucomicrobia: Akkermansia DOI
Yanli Zhang, Qiqiong Li, Huizi Tan

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 347 - 377

Published: Jan. 1, 2025

Citations

0

Gut microbiome composition likely affects the growth of Trachinotus ovatus by influencing the host's metabolism DOI
Chen‐Xu Wu,

Bao-Suo Liu,

Hua‐Yang Guo

et al.

Aquaculture International, Journal Year: 2025, Volume and Issue: 33(3)

Published: Feb. 10, 2025

Language: Английский

Citations

0

Gut Microbe Regulation of Sea Buckthorn for the Metabolic Syndrome DOI
Rina Wu,

Weihe Cang,

Shanshan Yang

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0

Akkermansia muciniphila: promises and pitfallsfor next-generation beneficial microorganisms DOI
Yantong Liu,

Zonglun Li,

Sze Ching Lee

et al.

Archives of Microbiology, Journal Year: 2025, Volume and Issue: 207(4)

Published: March 4, 2025

Language: Английский

Citations

0